How many 8-K filings has Regeneron Pharmaceuticals, Inc. filed?

Regeneron Pharmaceuticals, Inc. (REGN) has 11 8-K (Current Event Report) filings on record, spanning Jan 2024 to Apr 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Regeneron Pharmaceuticals, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Regeneron Pharmaceuticals, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Regeneron Pharmaceuticals, Inc. (REGN) — 8-K Filings

All 8-K filings from Regeneron Pharmaceuticals, Inc.. Browse 11 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (11)

Regeneron Pharmaceuticals Files 8-K on Financials — Apr 8, 2026 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on April 8, 2026, reporting results of operations and financial condition. The filing includes various XBRL documen
Regeneron Pharmaceuticals Files 8-K on Financials — Oct 6, 2025 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on October 6, 2025, to report on its results of operations and financial condition. The filing does not contain spe
Regeneron Pharmaceuticals Reports on Shareholder Vote Matters — Jun 18, 2025 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders on June 13, 2025. The filing details
Regeneron Pharmaceuticals Files 8-K — Feb 4, 2025 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on February 4, 2025, reporting on results of operations, other events, and financial statements. The filing does no
8-K Filing — Jan 13, 2025
Regeneron Pharmaceuticals Files 8-K on Financials — Oct 7, 2024 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on October 7, 2024, to report on its results of operations and financial condition. The filing does not contain spe
Regeneron Pharmaceuticals Files 8-K — Jul 8, 2024 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on July 8, 2024, to report results of operations and financial condition. The filing does not contain specific fina
Regeneron Pharmaceuticals Files 8-K on Security Holder Votes — Jun 20, 2024 Risk: low
Regeneron Pharmaceuticals, Inc. filed an 8-K on June 20, 2024, reporting on matters submitted to a vote of security holders on June 14, 2024. The filing details
Regeneron Files 8-K on Financial Results & Operations — Feb 2, 2024
Regeneron Pharmaceuticals, Inc. filed an 8-K on February 2, 2024, to report on its results of operations and financial condition. This filing indicates that the
Regeneron 8-K: Executive Comp/Officer Changes Reported Jan 26 — Jan 31, 2024
Regeneron Pharmaceuticals, Inc. filed an 8-K on January 31, 2024, reporting an event that occurred on January 26, 2024. This filing is categorized under 'Depart
Regeneron Files 8-K on Results, Reg FD Disclosure — Jan 8, 2024
Regeneron Pharmaceuticals, Inc. filed an 8-K on January 8, 2024, to disclose information under Items 2.02 (Results of Operations and Financial Condition), 7.01

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX